ProHealth health Vitamin and Natural Supplement Store and Health
Home  |  Log In  |  My Account  |  View Cart  View Your ProHealth Vitamin and Supplement Shopping Cart
800-366-6056  |  Contact Us  |  Help
Facebook Google Plus
Fibromyalgia  Chronic Fatigue Syndrome & M.E.  Lyme Disease  Natural Wellness  Supplement News  Forums  Our Story
Store     Brands   |   A-Z Index   |   Best Sellers   |   New Products   |   Deals & Specials   |   Under $10   |   SmartSavings Club

Trending News

Fighting Heartburn and Gerd Naturally – And Safely!

Natural Bladder Control, Go Less and Live More

Vital Molecule Increases Cellular Energy and Improves Cognitive Function

Top Vitamin and Mineral Deficiencies — Are You at Risk?

Trimming the spare tire: Canola oil may cut belly fat

How Pomegranate May Protect Against Cancer

Omega Fix for Obesity: How the Right Fats Fight Fat

The Onion: Cancer Fighter and Food Preserver

Probiotics improve cognition in Alzheimer's patients

Curcumin Reverses the Cellular Damage of Chronic Stress

 
Print Page
Email Article

Roche Cancer Drug Trial Succeeds Two Years Early

  [ 177 votes ]   [ Discuss This Article ]
www.ProHealth.com • April 14, 2004


ZURICH, April 13 (Reuters) - A late-stage clinical trial of cancer drug MabThera for treating the relapsed indolent form of non-Hodgkin's lymphoma met its primary goals two years earlier than expected, Roche Holding AG (ROG.VX) said on Tuesday. MabThera, also known as Rituxan, is already the Swiss healthcare group's top-selling drug. Genentech Inc (NYSE:DNA - News) and Biogen Idec (NasdaqNM:BIIB - News) co-market MabThera in the United States.

In the two-part phase III trial, patients were randomly assigned to get MabThera plus chemotherapy or chemotherapy alone as initial treatment, and responding patients received MabThera for two years as maintenance therapy or no further treatment. Analysis showed that "MabThera plus chemotherapy was significantly more effective than chemotherapy alone as initial treatment, and patients subsequently treated with MabThera maintenance for two years had significantly better progression-free survival than those who received no further treatment", a Roche statement said.

Roche's drug division chief, William Burns, noted that more than half of patients with relapsed indolent NHL are treated with chemotherapy alone at present and said the trial confirmed that MabThera should be the standard of care for patients with that form of the disease. An independent panel monitoring the trial data suggested changing the objective of the study to answer the question of whether MabThera maintenance therapy benefits patients receiving MabThera plus chemotherapy as initial treatment, so the trial will be amended in this way, Roche said.

Non-Hodgkin's lymphoma affects 1.5 million people worldwide. Indolent NHL, representing about 45 percent of NHL patients, is a slowly developing but serious cancer of the lymphatic system. MabThera is already indicated as a single-agent treatment for relapsed or refractory indolent NHL and received European approval in March 2002 for treating the aggressive form of NHL in combination with standard chemotherapy.



Post a Comment

Featured Products From the ProHealth Store
Vitamin D3 Extreme™ Mitochondria Ignite™ with NT Factor® Optimized Curcumin Longvida®


Article Comments



Be the first to comment on this article!

Post a Comment


 
Natural Pain Relief Supplements

Featured Products

Ultra ATP+, Double Strength Ultra ATP+, Double Strength
Get energized with malic acid & magnesium
Mitochondria Ignite™ with NT Factor® Mitochondria Ignite™ with NT Factor®
Reduce Fatigue up to 45%
Optimized Curcumin Longvida® Optimized Curcumin Longvida®
Supports Cognition, Memory & Overall Health
FibroSleep™ FibroSleep™
The All-in-One Natural Sleep Aid
Vitamin D3 Extreme™ Vitamin D3 Extreme™
50,000 IU Vitamin D3 - Prescription Strength

Natural Remedies

The Remarkable Benefits of Reishi Medicinal Mushrooms The Remarkable Benefits of Reishi Medicinal Mushrooms
Aches and Pains? A Simple Solution You'll Love Aches and Pains? A Simple Solution You'll Love
Milk Thistle: Trusted Support for Health & Healing in a Toxic World Milk Thistle: Trusted Support for Health & Healing in a Toxic World
Ubiquinol - A More Advanced Form of the Energy Producing Nutrient CoQ-10 Ubiquinol - A More Advanced Form of the Energy Producing Nutrient CoQ-10
Clinically Studied Joint Relief Product for FM & ME/CFS Clinically Studied Joint Relief Product for FM & ME/CFS

CONTACT US
ProHealth, Inc.
555 Maple Ave
Carpinteria, CA 93013
(800) 366-6056  |  Email

· Become a Wholesaler
· Vendor Inquiries
· Affiliate Program
SHOP WITH CONFIDENCE
Credit Card Processing
SUBSCRIBE TO OUR NEWSLETTERS
Get the latest news about Fibromyalgia, M.E/Chronic Fatigue Syndrome, Lyme Disease and Natural Wellness

CONNECT WITH US ProHealth on Facebook  ProHealth on Twitter  ProHealth on Pinterest  ProHealth on Google Plus

© 2016 ProHealth, Inc. All rights reserved. Pain Tracker App  |  Store  |  Customer Service  |  Guarantee  |  Privacy  |  Contact Us  |  Library  |  RSS  |  Site Map